| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1005503-17-2 | [4-(4-Chlorophenyl)cyclohexyl]methanol | C13H17ClO |
| 1005504-62-0 | 5-[[1-(2,6-Dichlorobenzyl)piperidin-4-yl]methoxy]quinazoline-2,4-diamine | C21H23Cl2N5O |
| 1005631-56-0 | 1-(2,2-Diethoxyethyl)-4-methyl-1H-pyrazole | C10H18N2O2 |
| 1005756-81-9 | 2-(Tetrahydro-2H-pyran-2-yl)ethanamine hydrochloride | C7H15NO.HCl |
| 1005763-14-3 | 4-fluoro-3-formylbenzamide | |
| 1005771-04-9 | 1,3-Dibromo-7-tert-butylpyrene | C20H16Br2 |
| 1005780-62-0 | TAK-593 | |
| 1005785-45-4 | 6-Chloroimidazo[1,2-a]pyridin-2-amine | C7H6ClN3 |
| 1005785-65-8 | (6-Chloroimidazo[1,2-b]pyridazin-2-yl)carbamic acid ethyl ester | C9H9ClN4O2 |
| 1006036-87-8 | MK-2894 | C25H22F3NO3S |
| 1006036-88-9 | MK-2894 Na salt | C25H22F3NO3S.Na |
| 1006061-35-3 | Fluphenazine decanoate hydrochloride | C32H44F3N3O2S.HCl |
| 1006062-27-6 | O-Acetyl losartan | C24H25ClN6O2 |
| 1006062-28-7 | Losartan trityl ether | C41H37ClN6O |
| 1006335-39-2 | N-(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-3-(1-ethyl-3-methyl-1H-pyrazol-4-yl)-4,5-dihydro-5-isoxazolecarboxamide | C21H24N6O3 |
| 1006348-71-5 | 3-(Trifluoromethyl)-1H-pyrazole-1-acetonitrile | C6H4F3N3 |
| 1006376-60-8 | (alphaS)-alpha-(Chloromethyl)-3,4-difluorobenzenemethanol | C8H7ClF2O |
| 1006376-61-9 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid ethyl ester | C12H12F2O2 |
| 1006376-62-0 | (1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxamide | C10H9F2NO |
| 1006377-63-4 | 3,4-Bis(2-methoxyethoxy)benzaldehyde oxime | C13H19NO5 |
| 1006378-06-8 | Gefitinib Impurity 17 | C15H19N3O5 |
| 1006381-03-8 | (4R)-4-Methyl-1,3,2-dioxathiolane 2,2-dioxide | C3H6O4S |
| 1006386-95-3 | L-Methionine-34S | C5H11NO2S |
| 1006436-44-7 | 1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-amine | C5H6F3N3 |
| 1006592-45-5 | (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide | C24H40N4O7S |
| 1006614-49-8 | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine | C9H9F2N |
| 1006717-55-0 | Prazosin-d8 | C19H13D8N5O4 |
| 1006865-32-2 | 1-Bromo-4-[[(2S)-3-methoxy-2-methylpropoxy]methyl]benzene | C12H17BrO2 |
| 1006872-82-7 | 2-Amino-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-4(1H)-pyrimidinone | C9H12FN3O4 |
| 1006873-58-0 | 5-Ethyl-2-methylpyridine borane | C8H11N.BH3 |
| 1006876-23-8 | [6-[(Dimethylamino)carbonyl]-3-pyridinyl]-boronic acid | |
| 1006876-27-2 | N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide | C14H21BN2O3 |
| 1006876-28-3 | 2-(N-Ethylaminocarbonyl)pyridine-5-boronic acid pinacol ester | |
| 1006876-77-2 | 6-(3-Bromophenyl)-4-phenyl-2(1H)-pyrimidinone | C16H11BrN2O |
| 1006890-01-2 | 7-Methoxy-4-(pyridin-3-yl)-6-[2-(quinolin-2-yl)ethoxy]quinazoline | C25H20N4O2 |
| 1006890-24-9 | 7-Methoxy-N,N-dimethyl-6-[2-(quinolin-2-yl)ethoxy]quinazolin-4-amine | C22H22N4O2 |
| 1006891-07-1 | 7-Methoxy-3-methyl-6-[2-(quinolin-2-yl)ethoxy]quinazolin-4(3H)-one | C21H19N3O3 |
| 1007089-84-0 | 3-(Chloromethyl)-5-methylpyridine hydrochloride | C7H7N.HCl |
| 1007112-64-2 | (3S)-3-(1,1-Dimethylethyl)morpholine | C8H17NO |
| 1007125-14-5 | 3-(Hydroxymethyl)cyclopentanol | C6H12O2 |
| 1007206-54-3 | 1H-Benzimidazole-5-boronic acid pinacol ester | C13H17BN2O2 |
| 1007207-67-1 | [5-[7-Methylsulfonyl-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-yl]amine | C15H19N7O3S |
| 1007207-89-7 | (3-Bromo-4-fluorophenyl)(morpholin-4-yl)methanone | C11H11BrFNO2 |
| 1007219-73-9 | 1-Methyl-1H-indazole-6-carboxylic acid methyl ester | C10H10N2O2 |
| 1007223-52-0 | [4-(trans-4-Ethylcyclohexyl)-2-fluorophenyl]boronic acid | C14H20BFO2 |
| 1007224-59-0 | 6-Hydroxywarfarin beta-D-glucuronide | C25H24O11 |
| 1007224-60-3 | 8-Hydroxywarfarin beta-D-glucuronide | C25H24O11 |
| 1007224-61-4 | 10-Hydroxywarfarin beta-D-glucuronide | C25H24O11 |
| 1007232-81-6 | N-[[[1-Methyl-1-(hydroxymethyl)ethyl]amino]thiocarbonyl]benzamide | C12H16N2O2S |
| 1007308-74-8 | 7-Fluoro-6-nitro-2,4(1H,3H)-quinazolinedione | C8H4FN3O4 |